Review of insurance claims shows how practice behavior changes after approval of durvalumab
The use of maintenance medication durvalumab for lung cancer has changed healthcare practices in the United States, according to a new study published at the International Association of American Scientists (IASLC). However, it doesn t always be the same.
Source: medicalxpress.comPublished on 2021-09-10